Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells
Marc A. Weniger, … , Martin-Leo Hansmann, Ralf Küppers
Marc A. Weniger, … , Martin-Leo Hansmann, Ralf Küppers
Published June 11, 2018
Citation Information: J Clin Invest. 2018;128(7):2996-3007. https://doi.org/10.1172/JCI95993.
View: Text | PDF
Research Article Hematology Immunology Article has an altmetric score of 7

Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells

  • Text
  • PDF
Abstract

Very few B cells in germinal centers (GCs) and extrafollicular (EF) regions of lymph nodes express CD30. Their specific features and relationship to CD30-expressing Hodgkin and Reed/Sternberg (HRS) cells of Hodgkin lymphoma are unclear but highly relevant, because numerous patients with lymphoma are currently treated with an anti-CD30 immunotoxin. We performed a comprehensive analysis of human CD30+ B cells. Phenotypic and IgV gene analyses indicated that CD30+ GC B lymphocytes represent typical GC B cells, and that CD30+ EF B cells are mostly post-GC B cells. The transcriptomes of CD30+ GC and EF B cells largely overlapped, sharing a strong MYC signature, but were strikingly different from conventional GC B cells and memory B and plasma cells, respectively. CD30+ GC B cells represent MYC+ centrocytes redifferentiating into centroblasts; CD30+ EF B cells represent active, proliferating memory B cells. HRS cells shared typical transcriptome patterns with CD30+ B cells, suggesting that they originate from these lymphocytes or acquire their characteristic features during lymphomagenesis. By comparing HRS to normal CD30+ B cells we redefined aberrant and disease-specific features of HRS cells. A remarkable downregulation of genes regulating genomic stability and cytokinesis in HRS cells may explain their genomic instability and multinuclearity.

Authors

Marc A. Weniger, Enrico Tiacci, Stefanie Schneider, Judith Arnolds, Sabrina Rüschenbaum, Janine Duppach, Marc Seifert, Claudia Döring, Martin-Leo Hansmann, Ralf Küppers

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 Total
Citations: 2 3 4 6 4 5 2 3 29
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (29)

Title and authors Publication Year
B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.
Weniger MA, Seifert M, Küppers R
Methods in molecular biology (Clifton, N.J.) 2025
Integrative bioinformatics and machine learning identify key crosstalk genes and immune interactions in head and neck cancer and Hodgkin lymphoma.
Qin M, Li X, Gong X, Hu Y, Tang M
Scientific reports 2025
Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis
Pan Y, Cengiz R, Kluiver J, Diepstra A, Van den Berg A
Cancers 2024
CD30 influences germinal center B-cell dynamics and the expansion of IgG1-switched B cells
Wang Y, Rambold U, Fiedler P, Babushku T, Tapken CL, Hoefig KP, Hofer TP, Adler H, Yildirim AÖ, Strobl LJ, Zimber-Strobl U
Cellular and Molecular Immunology 2024
Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels after B cell depletion with Ocrelizumab.
Gurski CJ, Hajiyeva Z, Veltri AJ, Fenton K, O'Dell S, Obeidat AZ, Dittel BN
Journal of neuroimmunology 2024
Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
Cellini A, Scarmozzino F, Angotzi F, Ruggeri E, Dei Tos AP, Trentin L, Pizzi M, Visentin A
Frontiers in Oncology 2023
Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances
Munir F, Hardit V, Sheikh IN, AlQahtani S, He J, Cuglievan B, Hosing C, Tewari P, Khazal S
International journal of molecular sciences 2023
Clonal composition and differentiation stage of human CD30+ B cells in reactive lymph nodes
Küppers R, Budeus B, Hartmann S, Hansmann ML
Frontiers in immunology 2023
A Mouse Model to Study the Pathogenesis of γ-herpesviral Infections in Germinal Center B Cells
Rambold U, Sperling S, Chew Z, Wang Y, Steer B, Zeller K, Strobl LJ, Zimber-Strobl U, Adler H
Cells 2023
The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
L Ziel-Swier, Y Liu, A Seitz, D de Jong, J Koerts, B Rutgers, R Veenstra, F Razak, A Dzikiewicz-Krawczyk, A van den Berg, J Kluiver
Genes & development 2022
CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies
Marhelava K, Krawczyk M, Firczuk M, Fidyt K
Cells 2022
Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma.
Bellitti E, Masciopinto P, Musto P, Arcuti E, Mastracci L, Opinto G, Ciavarella S, Guarini A, Cazzato G, Specchia G, Maiorano E, Gaudio F, Ingravallo G
Current oncology (Toronto, Ont.) 2022
NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells.
Pasqualucci L, Klein U
Biomedicines 2022
Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma
Hazane Leroyer E, Ziegler C, Moulin C, Campidelli A, Jacquet C, Rubio MT, Feugier P, Pagliuca S
Journal of Clinical Medicine 2022
Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
De Re V, Repetto O, Mussolin L, Brisotto G, Elia C, Lopci E, d\u2019Amore ES, Burnelli R, Mascarin M
Frontiers in Cell and Developmental Biology 2022
Mast Cell Modulation of B Cell Responses: An Under-Appreciated Partnership in Host Defence
AM Palma, MR Hanes, JS Marshall
Frontiers in immunology 2021
Molecular biology of Hodgkin lymphoma
MA Weniger, R Küppers
Leukemia 2021
CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin
L Lobastova, M Lettau, F Babatz, TD de Oliveira, PH Nguyen, BA Pauletti, AC Schauss, H Dürkop, O Janssen, AF Leme, M Hallek, HP Hansen
Frontiers in Cell and Developmental Biology 2021
Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
LV Fedorova, KV Lepik, NP Volkov, PV Kotselyabina, ES Borzenkova, MO Popova, AV Beynarovich, VV Baykov, AV Kozlov, IS Moiseev, NB Mikhailova, AD Kulagin
International Journal of Clinical Oncology 2021
Hodgkin lymphoma
JM Connors, W Cozen, C Steidl, A Carbone, RT Hoppe, HH Flechtner, NL Bartlett
Nature Reviews Disease Primers 2020
The critical role of CD4+ T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma
J Nagasaki, Y Togashi, T Sugawara, M Itami, N Yamauchi, J Yuda, M Sugano, Y Ohara, Y Minami, H Nakamae, M Hino, M Takeuchi, H Nishikawa
Blood Advances 2020
A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma
FZ Cader, X Hu, WL Goh, K Wienand, J Ouyang, E Mandato, R Redd, LN Lawton, PH Chen, JL Weirather, RC Schackmann, B Li, W Ma, P Armand, SJ Rodig, D Neuberg, XS Liu, MA Shipp
Nature Medicine 2020
Plasma cells, plasmablasts, and AID+/CD30+ B lymphoblasts inside and outside germinal centres: details of the basal light zone and the outer zone in human palatine tonsils
BS Steiniger, L Raimer, A Ecke, BA Stuck, Y Cetin
Histochemistry and Cell Biology 2020
Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring
ESMERAY E, KÜÇÜK C
2020
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion
K Wienand, B Chapuy, C Stewart, AJ Dunford, D Wu, J Kim, A Kamburov, TR Wood, FZ Cader, MD Ducar, AR Thorner, A Nag, AT Heubeck, MJ Buonopane, RA Redd, K Bojarczuk, LN Lawton, P Armand, SJ Rodig, JR Fromm, G Getz, MA Shipp
Blood Advances 2019
3D image analysis reveals differences of CD30 positive cells and network formation in reactive and malignant human lymphoid tissue (classical Hodgkin Lymphoma)
J Liebers, P Wurzel, KB Reisinger, ML Hansmann, F Bertolini
PloS one 2019
Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
K Vrzalikova, M Ibrahim, E Nagy, M Vockerodt, T Perry, W Wei, C Woodman, P Murray
Cancers 2018
TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation
GA Bishop, LL Stunz, BS Hostager
Frontiers in immunology 2018
Diagnosis of Hodgkin lymphoma in the modern era
HW Wang, JP Balakrishna, S Pittaluga, ES Jaffe
British Journal of Haematology 2018

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 10 X users
59 readers on Mendeley
See more details